On obesity, we are on the verge of some awesome breakthroughs! Here is what WebMD has to say about the topic:
More than a third of Americans are obese, suggesting that diet and exercise alone aren’t enough for millions of people trying to slim down.
Weight loss surgery is highly effective, but less than 2% of people who are candidates for it take that step, according to one estimate. “Patients are very reluctant to undergo surgery,” says Caroline Apovian, the director of the Nutrition and Weight Management Center at Boston Medical Center. “They just don’t realize that their obesity is not under their control, that it’s a disease.”
In January, the FDA approved the MAESTRO System, a pacemaker-like device designed to control hunger and fullness by blocking the vagus nerve, which extends from your brain to your stomach. The system, called the VBLOC, is one of a few intriguing approaches that researchers are studying as potential obesity treatments. VBLOC doesn’t alter the stomach or intestine like many of the weight loss surgeries.
The devices represent a field energized by recent FDA approvals of four new obesity drugs: Qsymia in 2012, Belviq in 2013, Contrave this past September, and Saxenda in late December.